cavendish cancer care
cavendish cancer care Company Information
Company Number
05086868
Website
http://cavcare.org.ukRegistered Address
34 wilkinson street, sheffield, S10 2GB
Industry
Other human health activities
Telephone
01142784600
Next Accounts Due
October 2024
Group Structure
View All
Shareholders
-0%
cavendish cancer care Estimated Valuation
Pomanda estimates the enterprise value of CAVENDISH CANCER CARE at £302.6k based on a Turnover of £798k and 0.38x industry multiple (adjusted for size and gross margin).
cavendish cancer care Estimated Valuation
Pomanda estimates the enterprise value of CAVENDISH CANCER CARE at £0 based on an EBITDA of £-48.7k and a 3.48x industry multiple (adjusted for size and gross margin).
cavendish cancer care Estimated Valuation
Pomanda estimates the enterprise value of CAVENDISH CANCER CARE at £1.5m based on Net Assets of £663.9k and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cavendish Cancer Care AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Cavendish Cancer Care Overview
Cavendish Cancer Care is a live company located in sheffield, S10 2GB with a Companies House number of 05086868. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2004, it's largest shareholder is unknown. Cavendish Cancer Care is a mature, small sized company, Pomanda has estimated its turnover at £798k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cavendish Cancer Care Health Check
Pomanda's financial health check has awarded Cavendish Cancer Care a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
4 Weak
Size
annual sales of £798k, make it in line with the average company (£666.3k)
£798k - Cavendish Cancer Care
£666.3k - Industry AVG
Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (5.2%)
-2% - Cavendish Cancer Care
5.2% - Industry AVG
Production
with a gross margin of 37.2%, this company has a comparable cost of product (37.2%)
37.2% - Cavendish Cancer Care
37.2% - Industry AVG
Profitability
an operating margin of -8.8% make it less profitable than the average company (7.2%)
-8.8% - Cavendish Cancer Care
7.2% - Industry AVG
Employees
with 26 employees, this is above the industry average (17)
26 - Cavendish Cancer Care
17 - Industry AVG
Pay Structure
on an average salary of £26.4k, the company has an equivalent pay structure (£24.3k)
£26.4k - Cavendish Cancer Care
£24.3k - Industry AVG
Efficiency
resulting in sales per employee of £30.7k, this is less efficient (£45.6k)
£30.7k - Cavendish Cancer Care
£45.6k - Industry AVG
Debtor Days
it gets paid by customers after 13 days, this is earlier than average (23 days)
13 days - Cavendish Cancer Care
23 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (18 days)
4 days - Cavendish Cancer Care
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cavendish Cancer Care
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 384 weeks, this is more cash available to meet short term requirements (126 weeks)
384 weeks - Cavendish Cancer Care
126 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7%, this is a lower level of debt than the average (24.9%)
7% - Cavendish Cancer Care
24.9% - Industry AVG
cavendish cancer care Credit Report and Business Information
Cavendish Cancer Care Competitor Analysis
Perform a competitor analysis for cavendish cancer care by selecting its closest rivals and benchmarking them against 12 key performance metrics.
cavendish cancer care Ownership
CAVENDISH CANCER CARE group structure
Cavendish Cancer Care has no subsidiary companies.
Ultimate parent company
CAVENDISH CANCER CARE
05086868
cavendish cancer care directors
Cavendish Cancer Care currently has 7 directors. The longest serving directors include Mrs Sarah Shepley (Jan 2006) and Mr Alan Spier (Feb 2013).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Sarah Shepley | England | 68 years | Jan 2006 | - | Director |
| Mr Alan Spier | 81 years | Feb 2013 | - | Director | |
| Ms Gillian Coverley | 52 years | Nov 2016 | - | Director | |
| Mr David Thurkettle | 63 years | Apr 2018 | - | Director | |
| Mr David Grey Mbe | England | 67 years | May 2018 | - | Director |
| Mr Michael Tunbridge | 72 years | Sep 2019 | - | Director | |
| Mrs Alison Clarke | England | 59 years | Feb 2020 | - | Director |
CAVENDISH CANCER CARE financials
Cavendish Cancer Care's latest turnover from January 2023 is £798 thousand and the company has net assets of £663.9 thousand. According to their latest financial statements, Cavendish Cancer Care has 26 employees and maintains cash reserves of £367.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2023 | Jan 2022 | Jan 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 798,048 | 813,288 | 544,634 | 847,309 | 778,787 | 847,586 | 826,141 | 507,632 | 516,815 | 528,769 | 563,488 | 500,643 | 492,202 | 555,611 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,203 | 3,047 | 94 | 148 | 42 | 55 | 220 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | -59,370 | 207,454 | 135,184 | -29,409 | -186,635 | 153,391 | 199,328 | -65,962 | 7,274 | 50,199 | 60,996 | -45,170 | 19,229 | 78,152 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -59,370 | 207,454 | 135,184 | -29,409 | -186,635 | 153,391 | 199,328 | -65,962 | 7,274 | 50,199 | 60,996 | -45,170 | 19,229 | 78,152 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -59,370 | 207,454 | 135,184 | -29,409 | -186,635 | 153,391 | 199,328 | -65,962 | 7,274 | 50,199 | 60,996 | -45,170 | 19,229 | 78,152 |
| Employee Costs | 686,577 | 485,184 | 333,776 | 731,964 | 749,557 | 584,934 | 523,205 | 489,185 | 414,930 | 367,861 | 384,664 | 415,830 | 364,263 | 349,125 |
| Number Of Employees | 26 | 18 | 18 | 20 | 21 | 13 | 11 | 11 | 10 | 7 | 9 | 9 | 9 | 9 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2023 | Jan 2022 | Jan 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 96,710 | 92,190 | 117,125 | 139,728 | 168,210 | 154,818 | 10,865 | 7,930 | 6,050 | 5,318 | 4,318 | 10,549 | 14,372 | 19,742 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 196,334 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 293,044 | 192,190 | 117,125 | 139,728 | 168,210 | 154,818 | 10,865 | 7,930 | 6,050 | 5,318 | 4,318 | 10,549 | 14,372 | 19,742 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 28,889 | 25,885 | 7,351 | 21,357 | 20,619 | 20,233 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 24,435 | 305,821 | 40,675 | 41,301 | 71,881 | 1,516 | 85,422 | 68,550 | 45,845 | 14,979 | 42,091 | 30,020 | 35,931 | 33,141 |
| Cash | 367,192 | 235,561 | 391,971 | 210,924 | 239,767 | 442,700 | 378,278 | 181,833 | 271,507 | 294,771 | 225,913 | 226,827 | 246,737 | 224,449 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 420,516 | 567,267 | 439,997 | 273,582 | 332,267 | 464,449 | 463,700 | 250,383 | 317,352 | 309,750 | 268,004 | 256,847 | 282,668 | 257,590 |
| total assets | 713,560 | 759,457 | 557,122 | 413,310 | 500,477 | 619,267 | 474,565 | 258,313 | 323,402 | 315,068 | 272,322 | 267,396 | 297,040 | 277,332 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 6,312 | 5,430 | 10,175 | 7,393 | 27,219 | 4,097 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 43,380 | 30,789 | 23,663 | 12,192 | 53,249 | 18,526 | 31,312 | 14,388 | 13,515 | 12,455 | 19,908 | 39,476 | 23,950 | 23,471 |
| total current liabilities | 49,692 | 36,219 | 33,838 | 19,585 | 80,468 | 22,623 | 31,312 | 14,388 | 13,515 | 12,455 | 19,908 | 39,476 | 23,950 | 23,471 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 7,500 | 13,125 | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 7,500 | 13,125 | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 49,692 | 36,219 | 41,338 | 32,710 | 90,468 | 22,623 | 31,312 | 14,388 | 13,515 | 12,455 | 19,908 | 39,476 | 23,950 | 23,471 |
| net assets | 663,868 | 723,238 | 515,784 | 380,600 | 410,009 | 596,644 | 443,253 | 243,925 | 309,887 | 302,613 | 252,414 | 227,920 | 273,090 | 253,861 |
| total shareholders funds | 663,868 | 723,238 | 515,784 | 380,600 | 410,009 | 596,644 | 443,253 | 243,925 | 309,887 | 302,613 | 252,414 | 227,920 | 273,090 | 253,861 |
| Jan 2023 | Jan 2022 | Jan 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 21,251 | 26,051 | 22,603 | 29,582 | 27,103 | 2,303 | 3,623 | 2,649 | 2,024 | 1,778 | 2,589 | 5,535 | 5,799 | 6,584 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -278,382 | 283,680 | -14,632 | -29,842 | 70,751 | -63,673 | 16,872 | 22,705 | 30,866 | -27,112 | 12,071 | -5,911 | 2,790 | 33,141 |
| Creditors | 882 | -4,745 | 2,782 | -19,826 | 23,122 | 4,097 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 12,591 | 7,126 | 11,471 | -41,057 | 34,723 | -12,786 | 16,924 | 873 | 1,060 | -7,453 | -19,568 | 15,526 | 479 | 23,471 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | -137,617 | -18,126 | -4,529 | 0 | |||||
| Change in Investments | 96,334 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -96,334 | -100,000 | 0 | 0 | 0 | -137,617 | -18,126 | -4,529 | 0 | |||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | -7,500 | -5,625 | 3,125 | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,203 | -3,047 | -94 | -148 | -42 | -55 | -220 |
| cash flow from financing | 0 | -7,500 | -5,625 | 3,125 | 10,000 | 0 | 0 | -2,203 | -3,047 | -94 | -36,650 | -42 | -55 | 175,489 |
| cash and cash equivalents | ||||||||||||||
| cash | 131,631 | -156,410 | 181,047 | -28,843 | -202,933 | 64,422 | 196,445 | -89,674 | -23,264 | 68,858 | -914 | -19,910 | 22,288 | 224,449 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 131,631 | -156,410 | 181,047 | -28,843 | -202,933 | 64,422 | 196,445 | -89,674 | -23,264 | 68,858 | -914 | -19,910 | 22,288 | 224,449 |
P&L
January 2023turnover
798k
-2%
operating profit
-69.9k
0%
gross margin
37.3%
+5.72%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2023net assets
663.9k
-0.08%
total assets
713.6k
-0.06%
cash
367.2k
+0.56%
net assets
Total assets minus all liabilities
Similar Companies
cavendish cancer care company details
company number
05086868
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
March 2004
age
20
accounts
Total Exemption Full
ultimate parent company
previous names
the cavendish centre (August 2020)
incorporated
UK
address
34 wilkinson street, sheffield, S10 2GB
last accounts submitted
January 2023
cavendish cancer care Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cavendish cancer care.
cavendish cancer care Companies House Filings - See Documents
| date | description | view/download |
|---|
